H.C. Wainwright & Co.
Tracked across 8 events · 67 articles · First seen Jan 29, 2026 · Last active Apr 06, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
H.C. Wainwright & Co. acted as the exclusive placement agent for Avalon GloboCare's private placement, facilitating the transaction. This role highlights their involvement in capital raising activities for biotechnology and technology companies.
Feb 27, 2026 · 10 articles
Business
H.C. Wainwright & Co. served as a joint bookrunning manager for Palvella Therapeutics' public offering.
Feb 24, 2026 · 8 articles
Business
H.C. Wainwright & Co. is acting as a co-manager for Candel Therapeutics' public offering, contributing to the syndicate managing the offering.
Feb 19, 2026 · 9 articles
Business
H.C. Wainwright & Co. is acting as a lead manager for Compass Pathways' public offering, providing support in the offering process.
Feb 19, 2026 · 7 articles
Business
H.C. Wainwright & Co. is acting as lead manager for Lexicon Pharmaceuticals' public offering, supporting the underwriting process. This indicates their involvement in the transaction.
Jan 29, 2026 · 8 articles
+ 3 more events
View on Dashboard
Lexicon Pharmaceuticals
underwriter
↔
H.C. Wainwright & Co.
H.C. Wainwright & Co. is an underwriter for Lexicon Pharmaceuticals' public offe
NEWSDESK
Track H.C. Wainwright & Co. live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard